DREYFUS, Nicolas Jacques Francois,LINDSAY-SCOTT, Peter James
申请号：
CR20190320
公开号：
CR20190320A
申请日:
2018.01.19
申请国别(地区):
CR
年份:
2019
代理人:
摘要：
The present invention provides a compound of formula one: or a prescription salt acceptable to medicines, and a prescription compound used to treat neurodegenerative diseases and disorders. For example, Alzheimer's disease: Current inventions provide a formula compound (I): or an acceptable salt, and the use of formula compounds (I) to treat neurodegenerative diseases and drugs as Alzheimer's disease.La presente invención proporciona un compuesto de Fórmula I: o una sal farmacéuticamente aceptable del mismo, y el uso de compuestos de Fórmula I para el tratamiento de enfermedades y trastornos neurodegenerativos, tales como la enfermedad de Alzheimer.The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula (I) for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
